Vanguard Amendment: Reports 0 Shares of Appian Corp
Appian Corp received an amendment to a Schedule 13G filing from The Vanguard Group reporting 0 shares beneficially owned, representing 0% of the common stock as shown in the amendment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Appian Corp received an amendment to a Schedule 13G filing from The Vanguard Group reporting 0 shares beneficially owned, representing 0% of the common stock as shown in the amendment. The filing includes a disclosure that certain Vanguard subsidiaries will report ownership separately after an internal realignment, per SEC Release No. 34-39538.
The report is signed by Ashley Grim, Head of Global Fund Administration, and is dated 03/26/2026 on the signature block.
Insights
Vanguard reports no beneficial ownership and disaggregates holdings after internal realignment.
The amendment shows The Vanguard Group with 0 shares and 0% ownership in Appian Corp as reported on the form. It cites SEC Release No. 34-39538 to explain that subsidiaries will report separately after an internal reorganization.
The practical effect is administrative: Vanguard’s consolidated beneficial ownership in Appian is not claimed here. Subsequent filings by Vanguard subsidiaries may show different holdings; check later ownership amendments for any reported positions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why does The Vanguard Group say it reports holdings separately for APPN?
Who signed the Schedule 13G/A amendment for APPN?
Will Vanguard subsidiaries report any APPN ownership separately?
Is the reported 0% ownership meaningful for APPN investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.